Manufacturing



As an innovative formulator and advanced processor, Ceapro specializes in proprietary manufacturing of a range of active ingredients and formulations. Ceapro's production facility is conveniently located in Leduc, Alberta where our rigorous quality control program ensures all aspects of production and testing (in our exclusive laboratory facility) meet strict standards.


Superior Quality Control

Due the natural variation of any plant source, Quality Control (QC) plays a crucial role to ensure that raw materials and processing aids meet the highest standards. Ceapro's products are standardized based on a clinical dose response of the active molecules. To further validate our results, third party laboratories are routinely used to corroborate our analytical data. Other QC activities include:
  • All raw materials and finished proucts entering and exiting the facility are quarantined until QC releases them once they have met Ceapro's specifications.

  • Custom manufactured processing equipment specifically meets the 3A Sanitary standard for the stringent dairy industry and eventually the future P3A sanitary standard for pharmaceutical manufacturing.

  • Ceapro's proprietary processing technologies use only environmentally friendly or "green" solvents and GRAS (Generally Recognized As Safe) raw and processing ingredients that are acceptable in all food and cosmetic formulations.

  • "Green" solvents are efficiently recycled using Ceapro patented technology so that solvents are not released into the environment.

  • Close proximity of our laboratory to the manufacturing area allows real-time monitoring of all aspects of production to ensure Ceapro's standards for finished products are met each and every time.

  • Critical Control Points are continuously monitored and tracked through each process.




Dedicated Research Laboratory


Later this year, Ceapro will have a wholly dedicated research laboratory to develop new analytical methods for future products and the development of new formulations for the human and animal healthcare industries. Ceapro scientists also collaborate with scientists from around the globe on many projects and provide consultation to other companies involved in the production of plant-based extracts.




Upcoming Developments

Future plans are underway at Ceapro to build a dedicated bioprocessing facility. Our innovative technologies reflect years of research and development into oat extraction and active ingredients used in the human and animal health industries.

Ceapro's research and development program will continue to discover and commercially develop new physiologically active plant extracts that are standardized specific to the active ingredient.